WuXi PharmaTech Co., Ltd.
253 Aidu Road
Waigaoqiao Free Trade Zone
Shanghai
200131
China
Tel: 86-21-5046-0095 Or 86-21-5046-1254<br>
Fax: 86-21-5046-1087
Website: http://www.pharmatechs.com/
321 articles about WuXi PharmaTech Co., Ltd.
-
WX LAWSUIT NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against WuXi PharmaTech (Cayman) Inc. - WX
3/7/2019
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of persons or entities who sold WuXi PharmaTech Inc. securities between September 1, 2015 and December 10, 2015, both dates inclusive or purchased securities during the Class Period and held such shares through December 10, 2015.
-
Lodo Therapeutics and Genentech Ink Strategic Collaboration Potentially Worth $1 Billion or More
5/9/2018
Lodo Therapeutics, based in New York, formed a strategic drug discovery collaboration with Genentech, a Roche company, in a deal potentially worth more than $1 billion. -
WuXi PharmaTech Invests In $7 Million A Round For Seattle's ApoGen Biotechnologies
12/14/2016
-
Week In Review: Three Months After Privatizing, WuXi PharmaTech Plans IPO For Biologics Unit
2/29/2016
-
WuXi PharmaTech To IPO Biologics Unit In Hong Kong
2/25/2016
-
Saturna Capital Invests $531,000 In WuXi PharmaTech
12/23/2015
-
WuXi PharmaTech And AstraZeneca PLC Form Strategic Alliance To Expedite Development Of Astrazeneca's Innovative Biologics Portfolio In China
12/16/2015
-
WuXi PharmaTech Presents 2015 Life Science And Chemistry Awards
12/14/2015
-
WuXi PharmaTech Completes $3.3 Billion Privatization
12/14/2015
-
WuXi PharmaTech And PRA Health Sciences Split Their China Clinical Stage JV
12/14/2015
-
WuXi PharmaTech Announces Completion Of Going Private Transaction
12/11/2015
-
WuXi PharmaTech And PRA Health Sciences Restructure Relationship In China
12/8/2015
-
WuXi PharmaTech Announces Shareholders' Approval Of Merger Agreement
11/25/2015
-
WuXi PharmaTech And Eli Lilly Announce Strategic Collaboration To Develop Novel Therapeutic In China
11/11/2015
-
ISS And Glass Lewis Recommend That WuXi PharmaTech Shareholders Vote "FOR" The Proposed Going-Private Transaction
11/11/2015
-
WuXi PharmaTech Congratulates Novira Therapeutics
11/6/2015
-
WuXi PharmaTech Announces Third-Quarter 2015 Results
11/4/2015
-
Gilead and WuXi PharmaTech Partner Up in China
11/2/2015
-
WuXi PharmaTech Launches Medical Device Testing Services In China
10/23/2015
-
WuXi PharmaTech Announces Extraordinary General Meeting Of Shareholders
10/20/2015